AGENDA

day 1

Friday, 12 September 2025

03:00 PM - 04:00 PM

REGISTRATION OPEN

WORKSHOPS

WORKSHOP 1

EEG IN DIAGNOSIS OF EPILEPSY

04:00 PM - 05:00 PM

moderator

DR. MAHFOUD ELBASHARI

speaker

DR. HINA ABBASI

speaker

DR. ABDULWAHAB ROMAN

OBJECTIVES:

  • Understand the basic principles of EEG recording and interpretation.
  • Identify key interictal and ictal EEG patterns associated with different types of epileptic seizures.
  • Differentiate between normal variants and pathological findings in EEG to avoid misdiagnosis.
  • Correlate EEG findings with clinical history.
  • Recognize the role of EEG in classifying epilepsy syndromes (e.g., focal vs. generalized epilepsy).

WORKSHOP 2

EPILEPSY SEMIOLOGY

05:00 PM - 06:00 PM

moderator

DR. MOHAMMED EL LAHAWI

speaker

PROF. NAJI RIACHI

speaker

DR. MOHAMAD HAYKAL

OBJECTIVES:

  • Understand the concept of seizure semiology and its importance in localizing seizure onset zones.
  • Describe the clinical features of focal and generalized seizures, including motor, sensory, autonomic, and cognitive symptoms.
  • Correlate semiological patterns with underlying brain regions.
  • Correlate lateralizing signs with epileptogenic zones.
  • Interpret semiological clues from patient history and video recordings.

06:00 PM - 06:30 PM

COFFEE BREAK

GALA DINNER PLENARY SESSION

MODERATORS

PROF. NAJI RIACHI

PROF. SUHAIL ALRUKN

06:30 PM - 06:50 PM

REAL-WORLD UK EXPERIENCE IN ALZHEIMER’S DISEASE MANAGEMENT

speaker

DR. EMER MACSWEENEY

06:50 PM - 07:10 PM

THE FIRST AND ONLY ORAL CGRP RECEPTOR ANTAGONIST TO TREAT & PREVENT MIGRAINE – WHAT’S NEW?

speaker

PROF. PETER MCALLISTER

07:10 PM - 07:30 PM

ADVANCING MS TREATMENT & CARE: MORE THAN A DECADE OF TRANSFORMATION

speaker

DR. MONA THAKRE

moderator

PROF. JIHAD INSHASI

07:30 PM - 07:50 PM

LEADING THE WAY IN MIGRAINE PREVENTION: THE FIRST & ONLY ANTI-CGRP WITH THE LONGEST CLINICAL DATA

speaker

DR. TAOUFIK ALSAADI

07:50 PM - 08:10 PM

ADVANCING MIGRAINE PREVENTION THROUGH EARLY INTENTIONAL IV THERAPY

speaker

PROF. ANDREW BLUMENFELD

08:10 PM - 08:30 PM

NAVIGATING GMG MANAGEMENT: REFINING POSSIBILITIES FOR PATIENTS

speaker

PROF. HEINZ WIENDL

MODERATOR

DR. ABUBAKER ALMADANI

08:30 PM - 08:50 PM

MIGRAINE FREEDOM IN ONE, FOR EPISODIC & CHRONIC MIGRAINE

speaker

DR. ALI MOHAMED HASSAN

08:50 PM - 10:00 PM

GALA DINNER

CLOSING REMARKS & END OF DAY 1

Edit Template

day 2

Saturday, 13 September 2025

07:00 AM - 08:00 AM

REGISTRATION OPEN

WORKSHOPS

WORKSHOP 3

NEUROCOGNITIVE DYSFUNCTION

08:00 AM - 08:50 AM

moderator

DR. MUSTAFA SHAKRA

speaker

DR. TAIM A. MUAYQIL

speaker

DR. ROAA A. KHALLAF

OBJECTIVES:

  • Define neurocognitive dysfunction and differentiate between normal aging, mild cognitive impairment (MCI), and dementia.
  • Outline a structured clinical approach to assessing patients with cognitive complaints.
  • Interpret basic cognitive testing results, such as MMSE or MoCA, in the context of clinical findings.

08:50 AM - 09:00 AM

WELCOME MESSAGE AND INTRODUCTION TO PLENARY SESSIONS

PROF. NAJI RIACHI

09:00 AM - 09:10 AM

KEYNOTE / HIGHLIGHT ABU DHABI’S GLOBAL LEADERSHIP IN PIONEERING NEUROTRCHNOLOGY AND ETHICAL INNOVATION

DR. ASMA AL MANNAEI

SESSION 1

DEMYELINATING DISEASES

MODERATORS

DR. AHMED SHATILA

DR. REEM ALSUWAIDI

DR. HALPRASHANTH D.S

09:10 AM - 09:30 AM

MS & COGNITIVE DECLINE

SPEAKER

DR. HAYTHUM TAYEB

09:30 AM - 09:50 AM

BLADDER DYSFUNCTION IN MS

SPEAKER

DR. GINA ZAMBRANO

09:50 AM - 10:10 AM

COMORBIDITIES IN MS

SPEAKER

DR. CALINE EL JADAM

10:10 AM - 10:30 AM

question and answer

10:30 AM - 10:50 AM

ADDRESSING THE MULTIPLE DIMENSIONS OF MS MANAGEMENT

speaker

DR. SAMAR FAROUK

moderator

PROF. JIHAD INSHASI

10:50 AM - 11:10 AM

PATIENT CHOICE MATTERS: OFFERING FLEXIBLE TREATMENT OPTIONS FOR MORE POEPLE WITH MS

SPEAKER

DR. DEEB KAYED

moderator

DR. MUSTAFA SHAKRA

11:30 AM - 12:00 PM

coffee break

SESSION 2

HEADACHE

MODERATORS

PROF. NAJI RIACHI

DR. ALI MOHAMED HASSAN

DR. USMAN MOGHAL

12:00 PM - 12:20 PM

IDIOPATHIC INTRACRANIAL HYPERTENSION & WEIGHT LOSS

SPEAKER

PROF. PETER MCALLISTER

12:20 PM - 12:40 PM

MIGRAINE IN PEDIATRIC POPULATIONS

SPEAKER

DR. DEEB KAYED

12:40 PM - 01:00 PM

TRIGGERS IN MIGRAINE

SPEAKER

DR. RODY EL NAWAR

01:00 PM - 01:20 PM

question and answer

01:00 PM - 01:20 PM

A SINGLE MEDICATION TO BOTH TREAT & PREVENT MIGRAINE: WHAT IS THE EVIDENCE?

speaker

PROF. PETER MCALLISTER

SPEAKER

tba

01:20 PM - 01:40 PM

ANTI-CGRP IN MIGRAINE PREVENTION: UNDERSTANDING SAFETY & RISK CONSIDERATIONS IN SPECIAL POPULATION - OLDER ADULTS

speaker

DR. MONA THAKRE

SPEAKER

tba

02:20 PM - 03:20 PM

LUNCH break

SESSION 3

DEMENTIA

MODERATORS

DR. JOSEF ALAWNEH

DR. EMAN GHAZI

DR. MOHAMMED ALKUWAITI

03:20 PM - 03:40 PM

TREATMENT GOAL THERAPIES IN AD

SPEAKER

PROF. CLAIRE PAQUET

03:40 PM - 04:00 PM

REVERSIBLE DEMENTIA

SPEAKER

DR. ROAA KHALLAF

04:00 PM - 04:20 PM

BIOMARKERS IN DEMENTIA

SPEAKER

DR. HANS FRYKMAN

04:20 PM - 04:40 PM

question and answer

04:00 PM - 04:20 PM

LATEST ADVANCES IN MCI AND MILD AD TREATMENT: NEW CLINICAL DATA

speaker

DR. EMER MACSWEENEY

SPEAKER

tba

04:20 PM - 04:40 PM

ADVANCING CARE FOR EARLY ALZHEIMER’S DISEASE

speaker

PROF. CLAIRE PAQUET

MODERATOR

DR. MUSTAFA SHAKRA

05:40 PM - 06:10 PM

coffee break

WORKSHOP 4

MANAGEMENT OF SPINAL PAIN SYNDROME

06:10 PM - 07:10 PM

moderator

DR. NADER HEBELA

speaker

DR. ERIC FRANCOIS

speaker

DR. MUHAMMAD FARHAN

OBJECTIVES:

  • Describe the common neurological causes of lower back pain and distinguish between radicular and non-radicular syndromes.
  • Review the neurosurgical indications and decision-making process for patients with lumbar spine pathology.
  • Outline the principles of pain management in chronic lower back pain.

CLOSING REMARKS & END OF DAY 2

Edit Template

day 3

Sunday, 14 September 2025

08:00 AM - 09:00 AM

ONSITE REGISTRATION

09:00 AM - 09:10 AM

WELCOME MESSAGE AND INTRODUCTION TO PLENARY SESSIONS

DR. MUSTAFA SHAKRA

SESSION 4

MOVEMENT DISORDER

MODERATORS

DR. SHIVAM OM MITTAL

DR. MOHAMMED SAIDAM

DR. INTISAR ALSHEHHI

09:10 AM - 09:30 AM

STIFF PERSON SPECTRUM DISORDERS

SPEAKER

DR. DUARTE MACHADO

09:30 AM - 09:50 AM

FUNCTIONAL MOVEMENT DISORDERS: NEUROPHYSIOLOGY, DX AND TREATMENT

SPEAKER

PROF. SHILPA CHITNIS

09:50 AM - 10:10 AM

NONINVASIVE BRAIN STIMULATION: TREATMENT OF PARKINSON’S DISEASE

SPEAKER

DR. KIRAN WAQAR

10:10 AM - 10:30 AM

question and answer

10:30 AM - 10:50 AM

NEWER APD TREATMENT HOPE & HYPE

speaker

DR. SHIVAM OM MITTAL

SPEAKER

tba

10:50 AM - 11:10 AM

ADVANCES IN COMT INHIBITION FOR THE MANAGEMENT OF PARKINSON’S DISEASE

speaker

DR. SHIVAM OM MITTAL

speaker

tba

11:30 AM - 12:00 PM

coffee break

SESSION 5

NEUROMUSCULAR

MODERATORS

DR. ABUBAKER ALMADANI

DR. MONA THAKRE

DR. ZULFIQAR HUSSAIN

12:00 PM - 12:20 PM

WHATS NEW IN AMYOTROPHIC LATERAL SCLEROSIS

SPEAKER

DR. ABDULLA AL SALTI

12:20 PM - 12:40 PM

HIGHLIGHT OF AAN 2025: NEUROMUSCULAR UPDATES

SPEAKER

DR. NAJWA AL-BUSTANI

12:20 PM - 12:40 PM

MYASTHENIA GRAVIS: UPDATE AND GCC EXPERIENCE

SPEAKER

DR. ALI ALSHEHRI

12:40 PM - 01:00 PM

RH EXPERIENCE IN NEWER MEDICATIONS OF MYASTHENIA GRAVIS

SPEAKER

DR. SALAMA KARAMASTAJI

01:00 PM - 01:20 PM

question and answer

02:20 PM - 03:20 PM

lunch

01:00 PM - 01:20 PM

COMPLEMENT INHIBITOR THERAPIES (C5ITS) IN GENERALISED MYASTHENIA GRAVIS (gMG): FROM CLINICAL STUDIES TO THE REAL WORLD

speaker

PROF. FRANCESCO SACCÀ

speaker

DR. ABUBAKER ALMADANI

SESSION 6

EPILEPSY

MODERATORS

DR. MOHAMAD HARB

DR. HEBA EL SAYED

DR. MUHAMMAD AL-KAYLANI

03:20 PM - 03:40 PM

OVERVIEW OF NEW ANTI-SEIZURE MEDICATIONS

SPEAKER

DR. TAOUFIK ALSAADI

03:40 PM - 04:00 PM

PSYCHOGENIC SEIZURES: DX & MANAGEMENT

SPEAKER

DR. AMIR JAVAID

04:00 PM - 04:20 PM

EPILEPSY & HOT WEATHER

SPEAKER

DR. ABDULLA ALKUWAITI

04:20 PM - 04:40 PM

question and answer

02:20 PM - 02:40 PM

TBA

speaker

tba

speaker

tba

03:20 PM - 03:40 PM

TBA

moderator

tba

speaker

tba

05:40 PM - 06:10 PM

coffee break

CLOSING REMARKS & END OF CONFERENCE

Edit Template

ACCME Accreditation Statement

Cleveland Clinic Abu Dhabi is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians

ACCME Credit Designation Statement

Cleveland Clinic Abu Dhabi designates this live activity for a maximum of 13.00 AMA PRA Category 1 Credits TM
Physicians should obtain only the credit commensurate with the extent of their participation in the activity.

Disclosure And Conflict Of Interest

The planning committee, faculty, and others in control of content have no relevant financial relationships with ineligible companies. All disclosures have been reviewed in accordance with ACCME Standards, and no conflicts of interest were identified.

Copyright © 5th Abu Dhabi Brain Conference All Rights Reserved | Design and Powered by : MCO

Copyright © 5th Abu Dhabi Brain Conference All Rights Reserved | Design and Powered by : MCO